Written by Tracey Walker

***excerpt***

Experts agree that this change could mean big things. “It’s always a notable development when some of the country’s largest employers change their relationships with PBMs,” says Lindsay Bealor Greenleaf, director at ADVI Health. “In lieu of rebates, Express Scripts will earn a fixed management fees plus additional at-risk compensation tied to outcomes. While delinking a PBM’s compensation from drugs’ list prices is a positive development, the next issue to watch is how these fees are structured.”

***end excerpt***

***

[/el-text]

View full article here